Bruker Corp. Stock
Bruker Corp. Stock
Bruker Corp. gained 0.800% compared to yesterday.
We see a rather positive sentiment for Bruker Corp. with 15 Buy predictions and 1 Sell predictions.
With a target price of 45 € there is a positive potential of 33.21% for Bruker Corp. compared to the current price of 33.78 €.
Our community identified positive and negative aspects for Bruker Corp. stock for the coming years. 0 users see the criterium "Revenue growth" as a plus for the Bruker Corp. stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Bruker Corp. in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bruker Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | 0.800% | 4.907% | -20.686% | -31.854% | -17.186% | - | - |
| Healthequity Inc. | -0.780% | 3.226% | -9.220% | -38.462% | -17.949% | 4.918% | -6.569% |
| Omnicell Inc. | -0.590% | 6.410% | -22.066% | -12.169% | -14.433% | -32.794% | -68.972% |
| Myriad Genetics | -2.140% | -2.646% | -25.506% | -72.121% | -30.566% | -78.983% | -84.881% |
Comments
Bruker (NASDAQ:BRKR) had its "sell" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Show more
Ratings data for BRKR provided by MarketBeat
Bruker (NASDAQ:BRKR) had its "buy" rating reaffirmed by analysts at Guggenheim.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker (NASDAQ:BRKR) had its "buy" rating reaffirmed by analysts at Guggenheim.
Show more
Ratings data for BRKR provided by MarketBeat
News
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide
Utah-based Grandeur Peak Global Advisors reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 709,697 shares in the third quarter, contributing to a net position change of $29.54 million
Why Bruker Stock Slumped Monday
Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake
On Tuesday, Massachusetts-based Lane Generational disclosed that it sold out of Bruker (NASDAQ:BRKR), liquidating 87,607 shares for an estimated $3.6 million in the third quarter.
According to a